Humira Gets Expanded Approval for Psoriatic Arthritis

older man getting a checkupThe Abbott Laboratories drug Humira (adalimumab) has been given expanded
approval by the U.S. Food and Drug Administration to slow structural joint
damage in people with psoriatic arthritis. The condition affects people who have
skin psoriasis.

Humira was initially